Evonik enjoys rapid growth in Mexico across all sectors, both in market share for existing products and as a result of acquisitions and diversification.
Sanofi has a diversified portfolio, ranging from innovative medicines including rare diseases, immunology, diabetes and cardiovascular to consumer healthcare products and vaccines.
CHIEF SENIOR RESEARCHER, TUBITAK MAM, GENETIC ENGINEERING AND BIOTECHNOLOGY INSTITUTE (GEBI)
The Genetic Engineering and Biotechnology Institute (GEBI) conducts researches and develops technologies in the field of genetic engineering and biotechnology with high added value by taking into consideration the developments in the world and the needs of the public and industrial sectors in Turkey.
TR-PHARM, founded in 2013, is a marketer of pharmaceuticals and biopharmaceuticals with a focus on high-tech R&D and the ambition to gain global recognition in bringing high-quality and cost-effective solutions in the healthcare industry.
Active since 1958, DEVA is a generics company with approximately 600 products ranging from APIs, formulations, sterile injectables and ampoules, BFS eye drops and animal health products.
Brazil’s mining sector has roared to life in 2024. This year, the country was in the international spotlight, hosting the G20 summit in Rio de Janeiro and preparing to host the COP 30 in 2025.